272 related articles for article (PubMed ID: 10025973)
21. U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases.
Vodegel RM; Jonkman MF; Pas HH; de Jong MC
Br J Dermatol; 2004 Jul; 151(1):112-8. PubMed ID: 15270879
[TBL] [Abstract][Full Text] [Related]
22. Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin. Specificity, sensitivity, and practical considerations.
Lazarova Z; Yancey KB
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):398-403. PubMed ID: 8784276
[TBL] [Abstract][Full Text] [Related]
23. The use of skin substrates deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease.
Vodegel RM; Kiss M; Cjm De Jong M; Pas HH; Altmayer A; Molnar K; Husz S; Van Der Meer JB; Jonkman MF
Eur J Dermatol; 1998 Mar; 8(2):83-5. PubMed ID: 9649654
[TBL] [Abstract][Full Text] [Related]
24. Case of epidermolysis bullosa acquisita with concomitant anti-laminin-332 antibodies.
Nishida E; Nishio E; Murashima H; Ishii N; Hashimoto T; Morita A
J Dermatol; 2018 Apr; 45(4):472-474. PubMed ID: 29205468
[TBL] [Abstract][Full Text] [Related]
25. Epidermolysis bullosa acquisita and anti-p200 pemphigoid as major subepidermal autoimmune bullous diseases diagnosed by floor binding on indirect immunofluorescence microscopy using human salt-split skin.
Goyal N; Rao R; Shenoi SD; Pai S; Kumar P; Bhogal BS; Schmidt E; Zillikens D
Indian J Dermatol Venereol Leprol; 2017; 83(5):550-555. PubMed ID: 28749386
[TBL] [Abstract][Full Text] [Related]
26. [Acquired localized epidermolysis bullosa. A case with scalp involvement and immunoelectron microscopic study].
Karpouzis A; Prost C; Cordoliani F; Viguier D; Blum L; Puissant A
Ann Dermatol Venereol; 1993; 120(6-7):464-8. PubMed ID: 8279794
[TBL] [Abstract][Full Text] [Related]
27. [Anti-laminin 5 mucous membrane pemphigoid].
Benoit S; Schmidt E; Sitaru C; Rose C; Goebeler M; Bröcker EB; Zillikens D
J Dtsch Dermatol Ges; 2006 Jan; 4(1):41-4. PubMed ID: 16503930
[TBL] [Abstract][Full Text] [Related]
28. Identification of cicatricial pemphigoid antigens.
Niimi Y; Zhu XJ; Bystryn JC
Arch Dermatol; 1992 Jan; 128(1):54-7. PubMed ID: 1739288
[TBL] [Abstract][Full Text] [Related]
29. Immunofluorescence serration pattern analysis as a diagnostic criterion in antilaminin-332 mucous membrane pemphigoid: immunopathological findings and clinical experience in 10 Dutch patients.
Terra JB; Pas HH; Hertl M; Dikkers FG; Kamminga N; Jonkman MF
Br J Dermatol; 2011 Oct; 165(4):815-22. PubMed ID: 21692774
[TBL] [Abstract][Full Text] [Related]
30. Childhood epidermolysis bullosa acquisita with autoantibodies against the noncollagenous 1 and 2 domains of type VII collagen: case report and review of the literature.
Mayuzumi M; Akiyama M; Nishie W; Ukae S; Abe M; Sawamura D; Hashimoto T; Shimizu H
Br J Dermatol; 2006 Nov; 155(5):1048-52. PubMed ID: 17034540
[TBL] [Abstract][Full Text] [Related]
31. Alterations of basement membrane zone in autoimmune subepidermal bullous diseases.
Woźniak K; Kowalewski C
J Dermatol Sci; 2005 Dec; 40(3):169-75. PubMed ID: 15990279
[TBL] [Abstract][Full Text] [Related]
32. Brunsting-Perry cicatricial bullous pemphigoid: a clinical variant of localized acquired epidermolysis bullosa?
Joly P; Ruto F; Thomine E; Delpech A; Balguerie X; Tron F; Lauret P
J Am Acad Dermatol; 1993 Jan; 28(1):89-92. PubMed ID: 8425977
[TBL] [Abstract][Full Text] [Related]
33. Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid.
Meijer JM; Diercks GF; Schmidt E; Pas HH; Jonkman MF
JAMA Dermatol; 2016 Aug; 152(8):897-904. PubMed ID: 27167149
[TBL] [Abstract][Full Text] [Related]
34. [Cicatricial pemphigoid--an important differential diagnosis in inflammatory mucous membrane changes].
Baier G; Zillikens D
Laryngorhinootologie; 1999 Nov; 78(11):632-7. PubMed ID: 10615658
[TBL] [Abstract][Full Text] [Related]
35. Studies of patients with anti-epiligrin cicatricial pemphigoid.
Yancey KB; Kirtschig G; Yee C; Lazarova Z
J Dermatol; 1995 Nov; 22(11):829-35. PubMed ID: 8557854
[TBL] [Abstract][Full Text] [Related]
36. Epidermolysis bullosa acquisita associated with epidermal-binding circulating antibodies.
Wakelin SH; Bhogal B; Black MM; Allen J; Wojnarowska F; Hashimoto T; Farr PM; Swain AF
Br J Dermatol; 1997 Apr; 136(4):604-9. PubMed ID: 9155969
[TBL] [Abstract][Full Text] [Related]
37. Identification and partial characterization of a novel 105-kDalton lower lamina lucida autoantigen associated with a novel immune-mediated subepidermal blistering disease.
Chan LS; Fine JD; Briggaman RA; Woodley DT; Hammerberg C; Drugge RJ; Cooper KD
J Invest Dermatol; 1993 Sep; 101(3):262-7. PubMed ID: 8370962
[TBL] [Abstract][Full Text] [Related]
38. Acquired junctional epidermolysis bullosa associated with IgG autoantibodies to the beta subunit of laminin-5.
Kirtschig G; Caux F; McMillan JR; Bedane C; Aberdam D; Ortonne JP; Eady RA; Prost C
Br J Dermatol; 1998 Jan; 138(1):125-30. PubMed ID: 9536235
[TBL] [Abstract][Full Text] [Related]
39. Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid.
Chan LS; Majmudar AA; Tran HH; Meier F; Schaumburg-Lever G; Chen M; Anhalt G; Woodley DT; Marinkovich MP
J Invest Dermatol; 1997 Jun; 108(6):848-53. PubMed ID: 9182809
[TBL] [Abstract][Full Text] [Related]
40. Inflammatory epidermolysis bullosa acquisita with coexistent IgA antibodies to plectin.
Buijsrogge JJ; de Jong MC; Meijer HJ; Dijk F; Jonkman MF; Pas HH
Clin Exp Dermatol; 2005 Sep; 30(5):531-4. PubMed ID: 16045687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
